Social impact of preventive HIV vaccine clinical trial participation: a model of prevention, assessment and intervention.
暂无分享,去创建一个
[1] S. Paxton,et al. AIDS-related discrimination in Asia , 2005, AIDS care.
[2] N. Duan,et al. Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come? , 2004, AIDS patient care and STDs.
[3] E. Vittinghoff,et al. Determinants of Enrollment in a Preventive HIV Vaccine Trial: Hypothetical Versus Actual Willingness and Barriers to Participation , 2004, Journal of acquired immune deficiency syndromes.
[4] S. Frey. Unique risks to volunteers in HIV vaccine trials. , 2003, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[5] T. Leitner,et al. Subtypes A, C, G, and recombinant HIV type 1 are circulating in Bangladesh. , 2002, AIDS research and human retroviruses.
[6] M. Allen,et al. Trial-related discrimination in HIV vaccine clinical trials. , 2001, AIDS research and human retroviruses.
[7] C. Grady. The Search for an AIDS Vaccine: Ethical Issues in the Development and Testing of a Preventive HIV Vaccine , 1995 .
[8] R. Belshe,et al. Interpreting HIV Serodiagnostic Test Results in the 1990s: Social Risks of HIV Vaccine Studies in Uninfected Volunteers , 1994, Annals of Internal Medicine.
[9] L. Temoshok. Behavioral research contributions to planning and conducting HIV vaccine efficacy studies. , 1994, AIDS research and human retroviruses.